BioHarvest Sciences Inc. Common Stock (BHST)

About BHST

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical…

Employees

89

Website

bioharvest.com/about/

Fundamentals

1-day range

$1.83$1.91

Market cap

$48.96M

P/E (trailing)

—

P/E (forward)

-5.49

EPS (trailing)

$-1.19

Dividend yield

—

Beta

-0.34

Avg. volume

50.6K

Forecasts

4 analyst ratings

Latest news

• Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5
  benzinga · 8/12/2026
• Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5
  Benzinga · 8/12/2026
• Roth Capital Maintains Buy on BioHarvest Sciences, Lowers Price Target to $8
  Benzinga · 8/12/2026
• Conference Call: BioHarvest Sciences Lowers FY2026 Sales Guidance from $42.000M-$48.000M to $37.000M-$40.000M vs $42.914M Est
  Benzinga · 8/11/2026
• BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/11/2026
• BioHarvest Sciences Revises FY26 CDMO Revenue Guidance to $4M-$5M from $4M-$6M; VINIA D2C Revenue Guidance to $33M-$35M from $38M-$42M
  Benzinga · 8/11/2026
• BioHarvest Sciences Enters Agreement For A Rare, Endangered Fragrance Plant Cell Culture With A UAE-Based Customer; Sees $20M-$30M In 2027-28 Sales
  Benzinga · 8/11/2026

Institutional Ownership

March 31, 2026

Total shares held

1.70M

Total value held

$5.70M

Institutional holders

20